Drugs / EMLA
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06023368 Comparator | Dec 2023 → Jun 2024 | childhood malignant neoplasm | Marianne Hutti | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06023368 ↗ |
| Route | Topical | “cream applied around the port prior to access” NCT06023368 ↗ |